TY - JOUR
T1 - Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis
T2 - Role of macrophages and fibroblasts in the liver
AU - Itoh, Michiko
AU - Ogawa, Yoshihiro
AU - Suganami, Takayoshi
N1 - Funding Information:
This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (16H05171, 16KT0110, 16K08732, 17H05500, and 19K07475) and AMED-CREST (JP19gm1210009). This work was also supported by research grants from Takeda Science Foundation, The Hori Sciences and Arts Foundation, Suzuken Memorial Foundation, the Japan Diabetes Society, MSD Life Science Foundation and Terumo Life Science Foundation. We thank Dr. Joel K. Elmquist (University of Texas South-western Medical Center) for his generous gift of MC4R-KO mice.
Publisher Copyright:
© 2020 Nagoya University.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - The pathological spectrum of nonalcoholic fatty liver disease includes simple steatosis and nonalcoholic steatohepatitis (NASH), the latter of which is the leading cause of cirrhosis and hepatocellular carcinoma. The available evidence shows that parenchymal cell injury and death trigger inflammation and tissue fibrosis. During the development of liver fibrosis, stromal cells dramatically changes in their cellular component and activation status responding to hepatocyte injury due to various etiologies. It is important to understand how cell death induces chronic inflammation and fibrosis, and the disease-specific macrophages and fibroblasts responsible for NASH development under metabolic stress. This review discusses recent progress in the understanding the pathogenesis of NASH, focusing on disease-specific macrophages and fibroblasts.
AB - The pathological spectrum of nonalcoholic fatty liver disease includes simple steatosis and nonalcoholic steatohepatitis (NASH), the latter of which is the leading cause of cirrhosis and hepatocellular carcinoma. The available evidence shows that parenchymal cell injury and death trigger inflammation and tissue fibrosis. During the development of liver fibrosis, stromal cells dramatically changes in their cellular component and activation status responding to hepatocyte injury due to various etiologies. It is important to understand how cell death induces chronic inflammation and fibrosis, and the disease-specific macrophages and fibroblasts responsible for NASH development under metabolic stress. This review discusses recent progress in the understanding the pathogenesis of NASH, focusing on disease-specific macrophages and fibroblasts.
UR - http://www.scopus.com/inward/record.url?scp=85091392582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091392582&partnerID=8YFLogxK
U2 - 10.18999/nagjms.82.3.391
DO - 10.18999/nagjms.82.3.391
M3 - Article
C2 - 33132423
AN - SCOPUS:85091392582
SN - 0027-7622
VL - 82
SP - 391
EP - 397
JO - Nagoya journal of medical science
JF - Nagoya journal of medical science
IS - 3
ER -